Table 13:

Event Rates, Treatment Effects, and Severity: Myocardial Infarction

Treatment Effects
Treatment	Annual Probability of Event	Standard Error	Source
Warfarin	0.005	0.0009	Connolly et al, 200915
LAAC device	0.005	0.0009	Connolly et al, 200915
Apixaban	0.005	0.0007	Granger et al, 201116
Dabigatran 110 mg	0.007	0.0011	Connolly et al, 200915
Dabigatran 150 mg	0.007	0.0011	Connolly et al, 200915
Rivaroxaban	0.009	0.0015	Patel et al, 201117
Intervention:Comparator	Odds Ratio	Standard Error	Source
Aspirin:warfarina	1.44	0.3562	Aguilar et al, 200753
Dual antiplatelet:warfarinb	0.77	0.0724	Cupareti et al, 200159
Severity of Myocardial Infarctions
Severity	Proportion	Standard Error	Source
Proportion of myocardial infarctions that are:
Fatal	0.080	0.0232	Walraven, 200258

Abbreviation: LAAC device, left atrial appendage closure device with delivery system.

^aAspirin treatment effects were applied to patients who discontinued pharmacologic therapy and who had a CHA₂DS₂VASc score of less than 2.

^bDual antiplatelet treatment effects were applied to patients two months post–myocardial infarction.